4U4K

Structure-based study to overcome cross-reactivity of novel androgen receptor inhibitors

DOI: 10.2210/pdb4U4K/pdb

Deposited: 2014-07-23 Released: 2015-07-29
Deposition Author(s): Lallous, N., Li, H., Dalal, K., Leblanc, E., Ban, F., Ciesielski, F., Chow, B., Morin, M., Singh, K., Rennie, P.S., Cherkasov, A.

Entry 4U4K was removed from the distribution of released PDB entries (status Obsolete) on 2016-04-13.
It has been replaced (superseded) by 8E1A.
Details: The entry is obsoleted due to pharmaceutical licensing

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.